Growth Capital

Arcola acquires bMedcare

By 21 February 2025No Comments

Arcola acquires bMEDcare 

YES Corporate Finance (“YES CF”) supports Arcola in raising acquisition financing by ABN AMRO for the acquisition of Lactona Holding B.V. (“Lactona”)  

About bMEDcare 

bMEDcare is an innovative developer and supplier of high-quality health and personal care products. The company includes the brands Dermolin and Essential Organics, which focus on skin-friendly care and natural nutritional supplements, respectively. https://www.bmedcare.com/  

 Dermolin offers a complete range of hypoallergenic skincare products, specifically developed for sensitive and easily irritated skin. Free from perfume, colorants, and parabens, the products are dermatologically tested and suitable for daily use without drying or irritating the skin. https://dermolin.nl/  

 Essential Organics stands for high-quality nutritional supplements made with carefully selected natural ingredients. The brand develops pure and effective formulas that support a healthy lifestyle and overall vitality. https://essentialorganics.nl/  

 bMEDcare products are available at pharmacies, drugstores, and online retailers. With a strong focus on scientifically backed formulas and strict quality controls, bMEDcare provides reliable and safe solutions for both personal care and general health. 

 About Healthcare Brands Group 

Healthcare Brands Group (“HBG”), a portfolio company of Arcola, is the umbrella organization behind various health and personal care brands. The group focuses on expansion through strategic acquisitions, aiming to build a strong and diverse brand portfolio. HBG includes brands such as Golden Naturals, Lactona, and the recently added Dermolin and Essential Organics. https://www.healthcarebrandsgroup.com/  

 Arcola 

Arcola, a rapidly growing independent private equity firm, invests in SMEs in the Benelux region. They focus on growing companies with strong market positions in industries such as industry, business services, and technology. https://arcola.eu/  

 The role of YES Corporate Finance 

YES Corporate Finance acted as the Debt Advisor for Arcola. The following activities were successfully carried out:: 

  • Preparation of a Financing Memorandum
  • Identifying and selecting the most suitable financier
  • Negotiating the best financing terms
  • Coordination of the due diligence process
  • Negotiating the financing documentation up to Signing and Closing 
Partner

Vincent Hafkamp

Vincent Hafkamp (1975) started as partner at YES Corporate Finance in September 2022. He has over 20 years of experience in M&A, business valuations and financing. Vincent was formerly active at Gilde Equity Management, ING Bank, KPMG Corporate Finance, and RiverBank. At Riverbank, Vincent was responsible for gaining foothold in The Netherlands. His broad experience allows him to advise a wide array of clients with different financial problems.
Associate Director

Eric Koelmans

Eric Koelmans (1994) joined YES Corporate Finance in 2019 and is currently an associate director. Eric holds a Bachelor in Business Economics with a specialization in Financing and Organization and a Master of Corporate Finance from the University of Amsterdam. Eric has gained experience at YES Corporate Finance as an intern after obtaining his Bachelor degree in 2018.
Analyst

Valentijn Achterberg

Valentijn Achterberg (1996) started as an analyst at Yes Corporate Finance in September 2023. He completed his bachelor’s degree in International Business Administration at the Vrije Universiteit and subsequently obtained a master’s degree in Finance & Investments from Erasmus University. During his bachelor’s studies, he gained international experience through an exchange program at ESSCA Shanghai Campus, China, and acquired work experience at ING. In addition to his master’s degree, he worked as a finance work-student at a life sciences scale-up, where he later took on the role of Financial Planning & Analysis analyst.
Recent deals
bMedcare

bMedcare

21 February 2025

Lactona

Lactona

21 February 2025

Novidam

Novidam

10 January 2025

Flagship

Flagship

28 October 2024